Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts What is the VIX Index? April 29, 2025 4 Biggest Cybersecurity ETFs in 2025 April 29, 2025 Initial Exploration Program Completed at Cosmo Gold Project April 29, 2025